Intrinsic Value of S&P & Nasdaq Contact Us

ASLAN Pharmaceuticals Limited ASLN

NASDAQ Global Market

SharesGrow Score
38/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ASLAN Pharmaceuticals Limited (ASLN) current share price is $0.60. The gold spot price is $4,825.20 per troy ounce. Using the formula: ASLN in gold = $0.60 × 31.1035 ÷ $4,825.20 = 0.0039 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ASLN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ASLN shares over the measured period.

ASLN in US Dollars
Gold in US Dollars
ASLN in Gold (grams per share)

Real Wealth Growth Rate

ASLN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ASLN}_{\text{gold}}(t) = \frac{P_{\text{ASLN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ASLN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ASLN}_{\text{gold}}^{(T)}}{\text{ASLN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ASLN}_\text{gold}^{(0)}$ = initial gold-price, $\text{ASLN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
NAMS
NAMS
NewAmsterdam Pharma Company N.V.
$34.44
-4.99%
GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
AGIO
AGIO
Agios Pharmaceuticals, Inc.
$33.30
+0.45%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
CTMX
CTMX
CytomX Therapeutics, Inc.
$4.54
+3.42%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message